El-Ghamrawy: The Pharmaceutical Track and Trace System Is a Strategic Step to Strengthen Oversight and Ensure Safe Medicines Reach Every Citizen
El-Ghamrawy: Every Medicine Pack Will Be Fully Traceable Within an Integrated Nationwide Digital System
El-Ghamrawy: We Are Establishing a New Phase of Transparency and Digital Control Over Pharmaceutical Supply Chains
Dr. Ali El-Ghamrawy, Chairman of the Egyptian Drug Authority (EDA), conducted a field visit to Giza Ambulance Pharmacy to launch and oversee the implementation of the first phase of the Pharmaceutical Track and Trace System. The system represents the national digital platform for tracking pharmaceutical products from the manufacturing stage until they reach the patient. This comes within the framework of the State’s efforts to strengthen pharmaceutical security and reinforce effective digital regulatory oversight.
He was accompanied by Dr. Tamer Elhossieny, Vice Chairman of the Egyptian Drug Authority; Eng. Basel Mubarak, Chairman of DAF Company; and Dr. Walid Saadeh, Chief Executive Officer of Supply Chains at the Egyptian Company for Drug Trading, representing the Chairman of the Board, in addition to several EDA leadership members.
This visit comes as part of Egypt’s comprehensive plan to enhance the safety and quality of medicines and to ensure the availability of safe, high-quality pharmaceutical products for every citizen. It also supports efforts to combat commercial fraud and counterfeit or expired medicines, thereby strengthening confidence in the Egyptian pharmaceutical system.
During the visit, a live demonstration of the system’s practical application inside the pharmacy was presented as a real-life model illustrating the mechanism for tracking each medicine pack through a unique serial number. This enhances transparency and effective oversight across pharmaceutical supply chains and strengthens control over the circulation of pharmaceutical products in the Egyptian market.
This step marks the first phase of nationwide implementation. The system has initially been applied to imported Schedule I products (narcotic substances), due to their specific regulatory nature and the importance of ensuring strict control over their circulation. Applying the system to this category will help guarantee their fair and organized availability across all

governorates through ambulance pharmacies, rather than limiting their availability to the Greater Cairo region only.
The system will subsequently be rolled out to other imported pharmaceutical products according to a phased implementation plan aimed at achieving comprehensive coverage of all products circulating in the Egyptian market.
During the visit, Dr. Ali El-Ghamrawy emphasized that digital medicine traceability has become a strategic component of the State’s healthcare sector development plan, stressing that Egypt adopts international best practices in tracking pharmaceutical products to safeguard citizens and enhance the efficiency of the pharmaceutical regulatory system.
He further noted that the Authority is working closely with all stakeholders in the pharmaceutical market to ensure coordination of roles and system readiness for full and effective nationwide implementation.
The visit program included a documentary video presentation explaining the mechanisms of the Pharmaceutical Track and Trace System and its role in regulating pharmaceutical supply. A practical application of the system was conducted inside the pharmacy, followed by extensive discussions with pharmacists and the technical support team on the challenges and opportunities associated with on-ground implementation. Key focus areas included enhancing pharmacy readiness to efficiently implement the system, raising awareness among pharmacists and pharmaceutical sector professionals about the importance of tracking every medicine pack, and supporting an integrated pharmaceutical oversight system to ensure that every patient receives safe and effective medicine.
The visit concluded with an introductory tour inside the pharmacy, underscoring the Egyptian Drug Authority’s commitment to implementing the latest digital solutions to enhance medicine safety, combat pharmaceutical fraud, and reinforce Egypt’s position as a regional model in digital transformation within the pharmaceutical sector. It was reaffirmed that the system is being implemented according to a clear phased plan, starting with imported Schedule I products (narcotic substances), reflecting a strong commitment and determination to achieve full nationwide implementation.